Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Asthma

  Free Subscription


Articles published in Allergy Asthma Proc

Retrieve available abstracts of 64 articles:
HTML format
Text format



Single Articles


    September 2017

  1. Evaluation of beclomethasone dipropionate (80 and 160 micrograms/day) delivered via a breath-actuated inhaler for persistent asthma.
    Allergy Asthma Proc. 2017 Sep 8. doi: 10.2500/aap.2017.38.4089.
    PubMed     Text format     Abstract available


    August 2017

  2. Indicators of poorly controlled asthma and health-related quality of life among school-age children in the United States.
    Allergy Asthma Proc. 2017 Aug 11. doi: 10.2500/aap.2017.38.4084.
    PubMed     Text format     Abstract available


    July 2017
  3. VANDEWALKER M, Hickey L, Small CJ
    Efficacy and safety of beclomethasone dipropionate breath-actuated or metered-dose inhaler in pediatric patients with asthma.
    Allergy Asthma Proc. 2017 Jul 14. doi: 10.2500/aap.2017.38.4078.
    PubMed     Text format     Abstract available


  4. MORALES-SUAREZ-VARELA M, Llopis-Gonzalez A, Vergara-Hernandez C, Fernandez-Fabrellas E, et al
    Asthma in older people hospitalized with influenza in Spain: A case-control study.
    Allergy Asthma Proc. 2017;38:277-285.
    PubMed     Text format     Abstract available


    June 2017
  5. D SHER L, Yiu G, Sakov A, Liu S, et al
    Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
    Allergy Asthma Proc. 2017 Jun 21. doi: 10.2500/aap.2017.38.4069.
    PubMed     Text format     Abstract available


  6. CORREN J, Kavati A, Ortiz B, A Colby J, et al
    Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review.
    Allergy Asthma Proc. 2017 Jun 19. doi: 10.2500/aap.2017.38.4067.
    PubMed     Text format     Abstract available


    May 2017
  7. MANSFIELD L, Yiu G, Sakov A, Liu S, et al
    A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
    Allergy Asthma Proc. 2017 May 24. doi: 10.2500/aap.2017.38.4061.
    PubMed     Text format     Abstract available


  8. TORCHYAN AA
    Asthma control in Saudi Arabia: Gender implications.
    Allergy Asthma Proc. 2017;38:239.
    PubMed     Text format    


  9. CHOI S, Kim SH, Lee JS
    Association between depression and asthma in Korean adults.
    Allergy Asthma Proc. 2017;38:238-239.
    PubMed     Text format    


  10. SYPNIEWSKA G, Krintus M, Fulgheri G, Siodmiak J, et al
    25-Hydroxyvitamin D, biomarkers of eosinophilic inflammation, and airway remodeling in children with newly diagnosed untreated asthma.
    Allergy Asthma Proc. 2017;38:238.
    PubMed     Text format    


  11. LICCARDI G, Calzetta L, Salzillo A, Apicella G, et al
    Letter to the Editor: Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma?
    Allergy Asthma Proc. 2017;38:238.
    PubMed     Text format    



  12. Abstracts from the Western Society of Allergy, Asthma and Immunology 2017 Annual Scientific Session, Fairmont Orchid, Big Island, Hawaii, January 29-February 2, 2017.
    Allergy Asthma Proc. 2017;38:237.
    PubMed     Text format    


  13. MANTI S, Leonardi S, Parisi GF, De Vivo D, et al
    High mobility group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate-severe asthma.
    Allergy Asthma Proc. 2017;38:197-203.
    PubMed     Text format     Abstract available


  14. PASHA MA, Sundquist B, Townley R
    Asthma pathogenesis, diagnosis, and management in the elderly.
    Allergy Asthma Proc. 2017;38:184-191.
    PubMed     Text format     Abstract available


  15. BELLANTI JA, Settipane RA
    Atopy, asthma, and the elderly: A paradigm for personalized therapy.
    Allergy Asthma Proc. 2017;38:167-169.
    PubMed     Text format    


  16. TORCHYAN AA
    Asthma control in Saudi Arabia: Gender implications.
    Allergy Asthma Proc. 2017;38:47-53.
    PubMed     Text format     Abstract available


  17. CHOI S, Kim SH, Lee JS
    Association between depression and asthma in Korean adults.
    Allergy Asthma Proc. 2017;38:37-46.
    PubMed     Text format     Abstract available


  18. SYPNIEWSKA G, Krintus M, Fulgheri G, Siodmiak J, et al
    25-Hydroxyvitamin D, biomarkers of eosinophilic inflammation, and airway remodeling in children with newly diagnosed untreated asthma.
    Allergy Asthma Proc. 2017;38:29-36.
    PubMed     Text format     Abstract available


  19. LICCARDI G, Calzetta L, Salzillo A, Apicella G, et al
    Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma?
    Allergy Asthma Proc. 2017;38:19-20.
    PubMed     Text format    


    March 2017
  20. KUEPPERS F, Sanders C
    State-of-the-art testing for alpha-1 antitrypsin deficiency.
    Allergy Asthma Proc. 2017;38:108-114.
    PubMed     Text format     Abstract available


  21. MILLER D, Wood C, Bateman E, LaForce C, et al
    A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma.
    Allergy Asthma Proc. 2017;38:157-164.
    PubMed     Text format     Abstract available


  22. VOGE GA, Carey WA, Ryu E, King KS, et al
    What accounts for the association between late preterm births and risk of asthma?
    Allergy Asthma Proc. 2017;38:152-156.
    PubMed     Text format     Abstract available


  23. CALABRIA CW, Hauswirth DW, Rank M, Sher L, et al
    American Academy of Asthma, Allergy & Immunology membership experience with venom immunotherapy in chronic medical conditions and pregnancy, and in young children.
    Allergy Asthma Proc. 2017;38:121-129.
    PubMed     Text format     Abstract available


  24. GUPTA A, Gupta LK, Rehan HS, Prakash A, et al
    Response to inhaled corticosteroids on serum CD28, quality of life, and peak expiratory flow rate in bronchial asthma.
    Allergy Asthma Proc. 2017;38:13-18.
    PubMed     Text format     Abstract available


  25. HENAO MP, Craig TJ
    Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlook.
    Allergy Asthma Proc. 2017;38:98-107.
    PubMed     Text format     Abstract available


    January 2017
  26. LAFORCE C, Taveras H, Iverson H, Shore P, et al
    Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.
    Allergy Asthma Proc. 2017;38:28-37.
    PubMed     Text format     Abstract available


  27. HAMZAVI ABEDI Y, Perkins AM, Morales MB
    Childhood obesity in pediatric patients with difficult-to-control asthma in a tertiary pediatric subspecialty clinic.
    Allergy Asthma Proc. 2017;38:63-69.
    PubMed     Text format     Abstract available


  28. KIM LH, Chang H, Namgoong S, Kim JO, et al
    Genetic variants of the gasdermin B gene associated with the development of aspirin-exacerbated respiratory diseases.
    Allergy Asthma Proc. 2017;38:4-12.
    PubMed     Text format     Abstract available


    November 2016
  29. WISNIEWSKI JA, McLaughlin AP, Stenger PJ, Patrie J, et al
    A comparison of seasonal trends in asthma exacerbations among children from geographic regions with different climates.
    Allergy Asthma Proc. 2016;37:475-481.
    PubMed     Text format     Abstract available


  30. STELMACH I, Sztafiska A, Jerzyska J, Podlecka D, et al
    New insights into treatment of children with exercise-induced asthma symptoms.
    Allergy Asthma Proc. 2016;37:466-474.
    PubMed     Text format     Abstract available


  31. ABU-KISHK I, Polakow-Farkash S, Elizur A
    Long-term outcome after pediatric intensive care unit asthma admissions.
    Allergy Asthma Proc. 2016;37:169-175.
    PubMed     Text format     Abstract available


  32. GONG F, Qian C, Zhu H, Zhu J, et al
    Circulating follicular T-helper cell subset distribution in patients with asthma.
    Allergy Asthma Proc. 2016;37:154-161.
    PubMed     Text format     Abstract available


  33. HOSHINO M, Ohtawa J, Akitsu K
    Effects of the addition of tiotropium on airway dimensions in symptomatic asthma.
    Allergy Asthma Proc. 2016;37:147-153.
    PubMed     Text format     Abstract available


  34. GUPTA RS, Singh AM, Walkner M, Caruso D, et al
    Hygiene factors associated with childhood food allergy and asthma.
    Allergy Asthma Proc. 2016;37:140-146.
    PubMed     Text format     Abstract available


  35. NGUYEN VQ, Ulrik CS
    Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma.
    Allergy Asthma Proc. 2016;37:125-139.
    PubMed     Text format     Abstract available


    September 2016
  36. QAQUNDAH PY, Taveras H, Iverson H, Shore P, et al
    Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma.
    Allergy Asthma Proc. 2016;37:350-8.
    PubMed     Text format     Abstract available


  37. LARENAS-LINNEMANN DE, Hauswirth DW, Calabria CW, Sher LD, et al
    American Academy of Allergy, Asthma & Immunology membership experience with allergen immunotherapy safety in patients with specific medical conditions.
    Allergy Asthma Proc. 2016;37:112-22.
    PubMed     Text format     Abstract available


  38. TENERO L, Piazza M, Sandri M, Azzali A, et al
    Effect of montelukast on markers of airway remodeling in children with asthma.
    Allergy Asthma Proc. 2016;37:77-83.
    PubMed     Text format     Abstract available


  39. LARENAS-LINNEMANN DE, Hauswirth DW, Calabria CW, Sher LD, et al
    American Academy of Allergy, Asthma Immunology membership experience with allergen immunotherapy safety in patients with specific medical conditions.
    Allergy Asthma Proc. 2016;37:112-122.
    PubMed     Text format     Abstract available


  40. SHIMODA T, Obase Y, Kishikawa R, Mukae H, et al
    Assessment of anti-inflammatory effect from addition of a long-acting beta-2 agonist to inhaled corticosteroid.
    Allergy Asthma Proc. 2016;37:387-93.
    PubMed     Text format     Abstract available


  41. BELLANTI JA, Settipane RA
    Relievers, controllers, and inhaler technique: A physician-patient challenge.
    Allergy Asthma Proc. 2016;37:347-9.
    PubMed     Text format    


  42. STELMACH I, Zaczeniuk M, Sztafinska A, Majak P, et al
    Serum tryptase level and inflammatory markers in exhaled breath condensate of children with exercise-induced symptoms.
    Allergy Asthma Proc. 2016;37:84-92.
    PubMed     Text format     Abstract available


  43. AKSU F, Sahin AD, Sengezer T, Aksu K, et al
    Effect of training by a physician on dynamics of the use of inhaler devices to improve technique in patients with obstructive lung diseases.
    Allergy Asthma Proc. 2016;37:98-102.
    PubMed     Text format     Abstract available


    August 2016
  44. RATNAYAKE A, Taveras H, Iverson H, Shore P, et al
    Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma.
    Allergy Asthma Proc. 2016.
    PubMed     Text format     Abstract available


  45. AMAR NJ, Moss MH, Kerwin EM, Li J, et al
    Safety and efficacy of beclomethasone dipropionate delivered by breath-actuated or metered-dose inhaler for persistent asthma.
    Allergy Asthma Proc. 2016.
    PubMed     Text format     Abstract available


    July 2016
  46. BITTNER JC, Hasegawa K, Probst BD, Mould-Millman NK, et al
    Smoking status and smoking cessation intervention among U.S. adults hospitalized for asthma exacerbation.
    Allergy Asthma Proc. 2016;37:318-23.
    PubMed     Text format     Abstract available


  47. CELEBI SOZENER Z, Aydin O, Mungan D, Misirligil Z, et al
    Obesity-asthma phenotype: Effect of weight gain on asthma control in adults.
    Allergy Asthma Proc. 2016;37:311-7.
    PubMed     Text format     Abstract available


  48. LIN J, Tang H, Chen P, Wang H, et al
    Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist.
    Allergy Asthma Proc. 2016;37:302-10.
    PubMed     Text format     Abstract available


  49. PEPPER AN, Cooke A, Livingston L, Lockey RF, et al
    Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Allergy Asthma Proc. 2016;37:279-90.
    PubMed     Text format     Abstract available


  50. GUARNACCIA S, Holliday CN, D'Agata E, Pluda A, et al
    Clinical and health promotion asthma management: an intervention for children and adolescents.
    Allergy Asthma Proc. 2016;37:70-6.
    PubMed     Text format     Abstract available


  51. SHIMODA T, Obase Y, Kishikawa R, Iwanaga T, et al
    Influence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthma.
    Allergy Asthma Proc. 2016;37:50-8.
    PubMed     Text format     Abstract available


    May 2016
  52. MILLER DS, Yiu G, Hellriegel ET, Steinfeld J, et al
    Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma.
    Allergy Asthma Proc. 2016.
    PubMed     Text format     Abstract available


  53. HOSHINO M, Ohtawa J, Akitsu K
    Association of airway wall thickness with serum periostin in steroid-naive asthma.
    Allergy Asthma Proc. 2016;37:225-30.
    PubMed     Text format     Abstract available


  54. UMARETIYA PJ, Swanson JB, Kwon HJ, Grose C, et al
    Asthma and risk of breakthrough varicella infection in children.
    Allergy Asthma Proc. 2016;37:207-15.
    PubMed     Text format     Abstract available


  55. KLAUSTERMEYER WB, Choi SH
    A perspective on systemic corticosteroid therapy in severe bronchial asthma in adults.
    Allergy Asthma Proc. 2016;37:192-8.
    PubMed     Text format     Abstract available


  56. BELLANTI JA, Settipane RA
    New insights to the many aspects of asthma: "A disease of a thousand faces" Lon Chaney (1883-1930): The Man of a Thousand Faces.
    Allergy Asthma Proc. 2016;37:177-9.
    PubMed     Text format    


  57. CARPAGNANO GE, Malerba M, Lacedonia D, Susca A, et al
    Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma.
    Allergy Asthma Proc. 2016;37:41-6.
    PubMed     Text format     Abstract available


  58. HSIAO HW, Wu CC, Lin MC, Wang CC, et al
    Comprehensive risk factors, asthma control, and life quality pathways in adults with asthma: A structural equation modeling analysis.
    Allergy Asthma Proc. 2016;37:31-40.
    PubMed     Text format     Abstract available



  59. For the Patient.
    Allergy Asthma Proc. 2016;37:263.
    PubMed     Text format    


  60. MAKOWSKA JS, Olszewska-Ziaber A, Bienkiewicz B, Lewandowska-Polak A, et al
    Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
    Allergy Asthma Proc. 2016;37:216-24.
    PubMed     Text format     Abstract available


  61. SKONER DP
    The tall and the short: Repainting the landscape about the growth effects of inhaled and intranasal corticosteroids.
    Allergy Asthma Proc. 2016;37:180-91.
    PubMed     Text format     Abstract available


  62. GIVEN J, Taveras H, Iverson H
    Prospective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter.
    Allergy Asthma Proc. 2016;37:199-206.
    PubMed     Text format     Abstract available


    September 2015
  63. BELLANTI JA, Settipane RA
    Children at risk: Conditions which can increase the occurrence of allergic disease.
    Allergy Asthma Proc. 2015;36:329-31.
    PubMed     Text format    


  64. LAI NS, Tsai TY, Koo M, Lu MC, et al
    Association of rheumatoid arthritis with allergic diseases: A nationwide population-based cohort study.
    Allergy Asthma Proc. 2015;36:99-103.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: